2-Chloro-6-fluoro-5-methylphenylboronic acid → HCID 86679878, Verbindung
Reaktionsgleichung
C[O:2][C:3](=[O:24])[C:4]1[CH:9]=[C:8]([C:10]2[S:11][CH:12]=[C:13]([C:15]3[CH:20]=[CH:19][C:18]([Cl:21])=[C:17]([Cl:22])[CH:16]=3)[N:14]=2)[CH:7]=[CH:6][C:5]=1Br.[Cl:25][C:26]1[CH:31]=[CH:30][C:29]([CH3:32])=[C:28]([F:33])[C:27]=1B(O)O>>[Cl:25][C:26]1[CH:31]=[CH:30][C:29]([CH3:32])=[C:28]([F:33])[C:27]=1[C:5]1[C:4]([C:3]([OH:2])=[O:24])=[CH:9][C:8]([C:10]2[S:11][CH:12]=[C:13]([C:15]3[CH:20]=[CH:19][C:18]([Cl:21])=[C:17]([Cl:22])[CH:16]=3)[N:14]=2)=[CH:7][CH:6]=1Komponenten
3
Versuchsvorschrift
Using the conditions of General Procedure A for Suzuki Coupling and Hydrolysis in Parallel Mode, 2-bromo-5-[4-(3,4-dichloro-phenyl)-thiazol-2-yl]-benzoic acid methyl ester (which may be prepared as described for Intermediate 6; 111 mg, 0.25 mmol) was reacted with 2-chloro-6-fluoro-5-methylphenylboronic acid (available from Combi-Blocks Inc.; 94 mg, 0.5 mmol). The resulting ester was hydrolyzed and the acid was purified to give 2′-chloro-4-[4-(3,4-dichloro-phenyl)-thiazol-2-yl]-6′-fluoro-5′-methyl-biphenyl-2-carboxylic acid (3 mg, 2%). 1H NMR (400 MHz, DMSO-d6) δ 13.18 (br s, 1H), 8.60 (d, J=2.0 Hz, 1H), 8.48-8.56 (m, 1H), 8.26-8.37 (m, 2H), 8.10 (dd, J=8.5, 2.0 Hz, 1H), 7.78 (d, J=8.5 Hz, 1H), 7.49 (d, J=7.8 Hz, 1H), 7.27-7.39 (m, 2H), 2.54 (s, 8H).